# A Study of Subcutaneous Lecanemab in Healthy Participants

> **NCT05045716** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lecanemab
- **DRUG:** Lecanemab

## Key facts

- **NCT ID:** NCT05045716
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-07
- **Primary completion:** 2021-12-07
- **Final completion:** 2021-12-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045716, "A Study of Subcutaneous Lecanemab in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05045716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*